Skip to main content
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Oncogene. 2020 Nov 15;40(3):564–577. doi: 10.1038/s41388-020-01552-0

Figure 6.

Figure 6.

Integrated model for the regulation of RRM2 protein levels by the mTORC1/2, ATR-CHK1, and WEE1 pathways. In previous work, we found that the inhibition of ATR-CHK1-WEE1 signaling enhances the CDK-mediated degradation of RRM2 (13). In the current work, we showed that the inhibition of mTORC1/2 blocks the synthesis of the RRM2 protein via the activation of 4E-BP1.